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Abstract
Background: Shiga toxin-producing Escherichia coli (STEC) are an important cause of gastroenteritis in Australia
and worldwide and can also result in serious sequelae such as haemolytic uraemic syndrome (HUS). In this paper
we describe the epidemiology of STEC in Australia using the latest available data.
Methods: National and state notifications data, as well as data on serotypes, hospitalizations, mortality and
outbreaks were examined.
Results: For the 11 year period 2000 to 2010, the overall annual Australian rate of all notified STEC illness was 0.4
cases per 100,000 per year. In total, there were 822 STEC infections notified in Australia over this period, with a low
of 1 notification in the Australian Capital Territory (corresponding to a rate of 0.03 cases per 100,000/year) and a
high of 413 notifications in South Australia (corresponding to a rate of 2.4 cases per 100,000/year), the state with
the most comprehensive surveillance for STEC infection in the country. Nationally, 71.2% (504/708) of STEC
infections underwent serotype testing between 2001 and 2009, and of these, 58.0% (225/388) were found to be
O157 strains, with O111 (13.7%) and O26 (11.1%) strains also commonly associated with STEC infections. The
notification rate for STEC O157 infections Australia wide between 2001-2009 was 0.12 cases per 100,000 per year.
Over the same 9 year period there were 11 outbreaks caused by STEC, with these outbreaks generally being small
in size and caused by a variety of serogroups. The overall annual rate of notified HUS in Australia between 2000
and 2010 was 0.07 cases per 100,000 per year. Both STEC infections and HUS cases showed a similar seasonal
distribution, with a larger proportion of reported cases occurring in the summer months of December to February.
Conclusions: STEC infections in Australia have remained fairly steady over the past 11 years. Overall, the incidence
and burden of disease due to STEC and HUS in Australia appears comparable or lower than similar developed
countries.
Background
Since 1982 gastroenteritis from Shiga toxin-producing
Escherichia coli (STEC), an E.coli strain with the capacity
to produce a cytotoxin similar to that produced by Shigella
spp., has been identified as a significant health problem in
the developed world [1,2]. Infections with STEC, of which
E.coli O157 is the most well known serotype, have been
recorded in many regions- including North America,
Western Europe, Japan, Central and South America, the
Middle and Far East, Africa and Australia [3,4]. Infections
by STEC are characterized by abdominal cramps and
acute bloody diarrhoea [5]; however, more serious seque-
lae may also result, including haemolytic uraemic syn-
drome (HUS) and associated complications, which can
lead to kidney failure and death in some individuals [3,6].
The majority of illness due to STEC appears to be
sporadic, although large outbreaks have been reported.
Cattle and sheep are the main reservoirs of STEC and it
is generally believed that the major transmission route is
foodborne, with the source of infection being the con-
tamination of food with animal faeces [7]. Foods that
have been found to be associated with infection are
poorly handled or inadequately cooked beef hamburgers
and ground beef [8,9], inadequately preserved meats
[10,11], raw or inadequately pasteurised dairy products
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[12,13] and juices [14,15], contaminated sprouted seeds
[16,17] and fresh produce [18,19]. In addition to the
foodborne transmission route, however, there have been
some large waterborne outbreaks [20] and other trans-
mission routes such as person-to-person and animal-to-
person also appear to play an important role, particularly
in sporadic cases [7,21]. Despite the fact that the inci-
dence of STEC infections appears to be much lower than
the incidence of other bacterial enteric infections caused
by Salmonella spp. and Campylobacter spp., the illness
caused can be severe and thus STEC is considered a sig-
nificant challenge to public health [22]. The extent of the
threat posed by infection with STEC and other Shiga
toxin producing E. coli pathotypes has been most
recently highlighted by the large outbreak of bloody diar-
rhoea and HUS associated with the rare E.coli serotype
O104:H4 [23]. This geographically widespread and severe
outbreak caused by contaminated sprouts resulted in
over 4000 cases and 50 deaths in Germany and 15 other
countries.
In this article we describe the epidemiology of STEC
in Australia using the latest available national and state
and territory surveillance data, as well as data on sero-
types, hospitalizations, mortality and outbreaks.
Methods
Australian notifiable disease surveillance data for STEC
and HUS
Information on the incidence of STEC infections and
HUS in Australia was obtained from the National Noti-
fiable Diseases Surveillance System (NNDSS) which is a
collation of data from state and territory health depart-
ments. Notification of laboratory confirmed STEC and
clinically diagnosed HUS to health departments has
been mandatory in Australia in all jurisdictions for the
11 year period, except Queensland and Western Austra-
lia where it became notifiable in 2001 [24].
The national notifiable diseases case definition for STEC
illness requires laboratory evidence only, which involves
either the isolation of STEC from faeces, the detection of
Shiga toxin from a clinical isolate of E. coli, or the identifi-
cation of the gene (stx1 and/or stx2) associated with the
production of Shiga toxin in E. coli by nucleic acid testing
on an isolate or raw bloody diarrhoea [24]. The national
case definition for HUS requires the presence of acute
microangiopathic anaemia on peripheral blood smear
(schistocytes, burr cells or helmet cells) and the presence
of at least one of: acute renal impairment (haematuria, pro-
teinuria or elevated creatinine level) or thrombocytopaenia,
particularly during the first 7 days of illness [25].
Using data obtained from the NNDSS website [26],
notification rates for both STEC infections and HUS
were examined for the 11 year period 2000-2010. HUS
rates included both diarrhoea associated HUS and non-
diarrhoea associated HUS.
South Australian surveillance data for STEC and HUS
South Australia is the state with the most comprehen-
sive surveillance for STEC illness in Australia. This was
initiated after a serious outbreak of paediatric HUS due
to contaminated mettwurst in 1995 [27]. In this State,
all stools are tested for presence of STEC where there is
evidence of blood in the stool, a clinical history of blood
in the stool, or where the requesting doctor queries
STEC infection or HUS [28]. Initially stools are screened
using real time PCR for the presence of stx1 and stx2
genes only and positive specimens are tested with a
multiplex PCR for virulence genes stx1, stx2, eae, hlyA,
saa, and serotype genes O111, O157, O113 [29]. All fae-
cal samples that screen positive for stx1 and stx2 are also
cultured, and with few exceptions, STEC isolates are
obtained, all of which are serotyped.
National OzFoodNet datasets
The Commonwealth Department of Health and Ageing
established the OzFoodNet network to enhance surveil-
lance for foodborne disease across Australia in 2000
[30]. OzFoodNet network partners include the National
Centre for Epidemiology and Population Health at The
Australian National University, the Public Health
Laboratory Network, and all eight States and Territories
of Australia. OzFoodNet maintains a number of data-
bases with comprehensive information on foodborne
disease in Australia.
National OzFoodNet enhanced data on serotypes
National data on serotype distribution was analysed using
OzFoodNet enhanced data on serotypes for 2001 to 2009.
It is important to note that there is some variation in
methods of testing and reporting on serotypes across the
different states and territories that may influence the sero-
types reported and included in this database. OzFoodNet
enhances this serotype data each year before producing
their annual report by checking for completeness and
accuracy. Changes made to the data by OzFoodNet for
their annual reports may not always be incorporated into
state and territory surveillance systems. Similarly, state
and territory data may be updated at a later time following
the publication of the OzFoodNet annual report and these
changes will not be reflected in the OzFoodNet data.
Small differences in numbers may hence result between
OzFoodNet data and the datasets maintained by the indi-
vidual states and territories.
National OzFoodNet outbreak register data
The OzFoodNet Outbreak Register is a collation of
information on all outbreaks of gastroenteritis since
2001. Data describing all STEC outbreaks that had
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occurred in Australia between 2001 and 2009 were
examined. Outbreak register data was cross checked
with annual reports and adjusted accordingly.
Hospital and mortality data for STEC and HUS
The National Hospital Morbidity Database [31] was exam-
ined for episodes of admission for STEC illness (ICD 10
codes A04.0 toA04.4) and HUS (ICD-10 code D59.3)
where these illnesses were coded as the principal diagnosis
(main reason for admission) during the 9 year period
1999/2000 to 2007/08. The rubrics for ICD-10 AM [32]
codes used to identify hospitalisations and deaths for prob-
able STEC infection and HUS were the following: A04.0:
Enteropathogenic E.coli infection; A04.1 Enterotoxigenic
E.coli infection; A04.2: Enteroinvasive E.coli infection;
A04.3: Enterohaemorrhagic E.coli infection; A04.4: other
intestinal E.coli infections; and D59.3: Haemolytic uraemic
syndrome. While A04.3 is the most appropriate descrip-
tion for STEC infection, it was likely that other related
codes were also used during coding of STEC infection
admissions and therefore the results tables refer to epi-
sodes coded to the wider range of codes. The hospitaliza-
tion data are recorded as episodes of admission and do
not give information on repeat admissions for the same
person. The data are provided as financial years (July to
June the following calendar year) and so are not strictly
comparable with data from other datasets provided by
calendar year.
Mortality unit record data were obtained from the Aus-
tralian Bureau of Statistics and examined for the period
2000-2007. The number of deaths was identified where
HUS (ICD-10 code D59.3) was categorized as the main
cause of death, as a contributing cause of death, or as a
significant condition related to death. Deaths where there
was no HUS but there was likely STEC infection (ICD-10
codes A04.0 to A04.4) were also identified.
Population data
Annual rates were calculated using numerator data of the
number of annual notifications, hospitalizations or deaths
and denominator data of the appropriate midyear popu-
lation from the Australian Bureau of Statistics [33,34].
Ethics
Ethics approval for the analysis of unit record data was
obtained from the Australian National University
Human Research Ethics Committee.
Results
Incidence of STEC illness
For the 11 year period 2000 to 2010, the overall annual
Australian notification rate of STEC illness was 0.4 cases
per 100,000 per year, with annual rates ranging from 0.2
to 0.6 per 100,000 per year (Table 1). Overall, the number
and rates of notifications of STEC nationally appeared to
increase slightly between 2000 and 2010, with the annual
rate being approximately 0.2 cases per 100,000 per year
between 2000 and 2004, and approximately 0.5 cases per
100,000 per year between 2005 and 2010. In South Austra-
lia, the jurisdiction with the most comprehensive surveil-
lance in the country, the notification rate was considerably
higher over this period, with 2.4 cases per 100,000 per
year (ranging from 1.8 to 3.8 cases per 100,000 per year).
The notification rate in South Australia appeared to be
fairly steady over this period, notwithstanding a spike in
2009 due to a number of outbreaks which occurred in this
state during this year.
The examination of the annual number of notifications
across each of the jurisdictions indicated that the Australian
Capital Territory and Tasmania had the lowest numbers of
cases and lowest rates with only 1 and 2 notifications over
the eleven year period between 2000 and 2010, respectively
(Table 2). In contrast, the jurisdiction with the highest
Table 1 Notification of human STEC illnesses in Australia and in the state of South Australia, 2000 to 2010
Year N, national
notifications




Rate, South Australia notification per
100,000/year
2000 37 0.2 33 2.2
2001 46 0.2 27 1.8
2002 59 0.3 39 2.5
2003 52 0.3 37 2.4
2004 51 0.2 30 1.9
2005 84 0.4 39 2.5
2006 70 0.3 35 2.2
2007 106 0.5 40 2.5
2008 107 0.5 39 2.4
2009 130 0.6 62 3.8
2010 80 0.4 32 1.9
Total 822 0.4 413 2.4
Source: Data extracted from National Notifiable Diseases Surveillance System website [26]
Vally et al. BMC Public Health 2012, 12:63
http://www.biomedcentral.com/1471-2458/12/63
Page 3 of 12
number of notifications by a fair margin was South
Australia 413 notifications. The number of notifications
remained steady in most of the jurisdictions, however, in
New South Wales, Victoria and Queensland, there
appeared to be a slight increase in the number of notifica-
tions from around the middle part of the period.
Age and sex distribution of STEC
Sixteen percent of all STEC cases nationally occurred in
children < 5 years and the national notification rate was
highest for this age group at 0.9 cases per 100,000 per year
with all other age groups ranging from 0.3 to 0.5 cases per
100,000 per year (Table 3). In the adult age range 15-59
years there were slightly more notifications for females
compared to males. Age/sex distributions across all of the
states in Australia were fairly similar (data not shown).
Incidence and distribution of STEC serogroups
Between 2001 and 2009, 504 of 708 (71.2%) STEC illness
notifications in Australia had serotyping information and
results were recorded in the OzFoodNet database contain-
ing enhanced data on serotypes. Although 116 isolates
were unable to be typed for various reasons, for the
remaining 388 a known serotype was established, and of
these 225 (58%) were found to be O157 strains, with 163
(42%) non O157 STEC strains. Among those with an iden-
tified serotype, the proportion of strains with O157 sero-
type over this period ranged from a low of 39% (in 2005)
to a high of 74% (in 2002), with no obvious trend apparent
(Figure 1). The overall average annual rate of notifications
of confirmed STEC O157 illnesses in Australia between
2001 and 2009 was 0.12 cases per 100,000 per year.
In South Australia, where there is more extensive
STEC testing using sensitive genetic testing methods
compared with other states, 460 cases of STEC infection
were notified between 1997 and 2009 and 281 (61%) had
serotype information [28]. Among the cases with sero-
type information, O157 strains accounted for 140 cases
(50%). The annual rate of notifications of STEC O157 for
South Australia was 0.7 cases per 100,000 per year
between 1997 and 2009. Based on 2001-2009 OzFoodNet
data amongst non O157 STEC infections with serotype
information, O111 (13.7% of serotyped strains) and O26
(11.1%) were found to be the most represented ser-
ogroups. Serotypes O113, O55 and O86 also contributed
to non O157 notifications. The full spectrum of ser-
ogroups detected in Australia between 2000 and 2009 is
summarized in Table 4.
Incidence of haemolytic uraemic syndrome in Australia
There were a total of 169 notifications of HUS notified
nationally to NNDSS in the period 2000 to 2010 as
shown by year and jurisdiction in Table 5, and by age
and sex in Table 6. The overall average annual rate of
notification for HUS in the 11 year period 2000-2010
was 0.07 cases per 100,000 per year. The notification
rates for HUS ranged from below 0.05 cases per 100,000
per year in the Australian Capital Territory, Tasmania
and Western Australia to a high of 0.13 cases per
100,000 per year in New South Wales. The number of
notifications increased in New South Wales from 2003
to 2008 but other states remained stable. Nationally,
there were nearly twice as many females (n = 29) than
males (n = 15) notified with HUS in the age group 16-
60 year, and children under 5 years had the highest rate
of HUS at 0.49 cases per 100,000 per year (Table 6).
Data were not available for the number of HUS cases
that were diarrhoea associated or STEC positive.
Hospitalisations and deaths due to STEC infection
National hospitalisation data indicated that there were
152 admissions for STEC infection as a principal diag-
nosis over the 9 year period between 1999/2000 and
2007/08, giving a rate of 0.08 admissions per 100,000
Table 2 Number of notifications of STEC illness by year
and jurisdiction, 2000 to 2010
YEAR NSW VIC ACT WA QLD SA TAS NT
2000 1 3 0 NN* NN* 33 0 0
2001 1 1 0 3 14 27 0 0
2002 6 5 0 4 5 39 0 0
2003 3 3 0 3 6 37 0 0
2004 5 4 0 0 10 30 0 0
2005 16 8 0 12 9 39 2 0
2006 10 5 0 3 15 35 0 2
2007 23 13 1 2 24 40 0 3
2008 19 11 0 0 38 39 0 0
2009 21 16 0 6 24 62 0 1
2010 10 12 0 8 18 32 0 0
TOTAL 115 81 1 41 163 413 2 6
Yearly Rate/100,000 0.17 0.14 0.03 0.18 0.37 2.4 0.04 0.07
*NN= Not notifiable
Source: Data extracted from National Notifiable Diseases Surveillance System
website [26]
Table 3 Notifications STEC in Australia 2000 to 2010, by
age and sex
Males Females Total Rate, notifications per
100,000/year
< 5 years 63 62 125 0.9
5 - 14
years
71 55 126 0.4
15 - 59
years
157 205 362 0.3
60+ years 80 128 208 0.5
Total 371 450 822 0.4
Source: Data extracted from National Notifiable Diseases Surveillance System
website [26]
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per year. There were three deaths from STEC infection
where HUS was not recorded as a co-condition in the
period 2000-2007, with all of these occurring in people
over 60 years of age. However, South Australian notifi-
able surveillance data from a 13 year period 1997-2009
indicated that 33% (150/460) of STEC cases were
admitted to hospital for any complication, including
HUS, giving a much higher population rate of approxi-
mately 0.8 cases per 100,000 per year [28]. The rate was
greater in the last 5 years 2005-2009 at about 1 per
100,000 per year.
Hospitalisations and deaths due to HUS
There were 670 hospital admissions recorded in the hospi-
talisation database nationally for HUS between 1999/2000
and 2007/2008, indicating a rate of hospitalisation of 0.37
per 100,000 per year (Table 7), which is a considerably
higher rate than the number of new cases of HUS reported
to NNDSS for almost the same period (0.08 cases per
100,000 per year). Over time the annual hospitalisation
rates for HUS appear to have increased slightly.
National hospitalisation episode rates for HUS were
highest for children < 5 years at 1.47 per 100,000 per year.
The overall rates were similar for males (0.36 cases per
100,000 per year) and females (0.38 cases per 100,000 per
year) although in the youngest age group < 5 years, there
were twice as many males hospitalised (n = 116) as
females (n = 56). Among people aged 16-60 years there
were more hospitalisations for women (n = 189) than men
(n = 100), reflecting the distribution of HUS notifications.
There were 14 deaths recorded in the Australian Mortal-
ity Database from 2000 to 2007 where HUS was the main
underlying cause of death, representing a rate of 0.01
deaths per 100,000 per year. In another 18 deaths, HUS
was listed as an additional contributing cause of death, or
as a significant condition, but not as the main underlying
cause. When all 32 deaths were counted, the rate increased
to 0.02 deaths per 100,000 per year. There was no differ-
ence by sex with 16 deaths for each of males and females,
and there was no apparent trend over time. Among the
deaths where the main underlying cause was HUS, two







Figure 1 Proportion STEC O157 and non O157 isolates (of those with a known serotype) reported in Australia between 2001 and
2009.
Table 4 Serotypes detected in Australia from OzFoodNet enhanced data 2001-2009 (n = 504 isolates)
Percentage of isolates with a
known serotype
Serotypes
Common* (> 1%) O157 (58%), O111 (13.7%), O26 (11.1%), O113 (3.6%), O55 (1.3%), O86 (1.0%)
Uncommon* (< 1%) O2, O5, O28, O49, O77, O88, O103, O112, O124, O128, O130, O153, O145, O166, O172, O174, O178, O141, OR,
O123, O165, ONT:H2/H7/H18/H19/H49
Source: OzFoodNet Unpublished Data, 2010
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and nine were 50 = years. Among those with HUS as a
contributing cause but not an underlying cause, one was 0-
4 years, one was 5-9 years, five were 20-50 years, and ele-
ven were 50 = years. The age specific death rates indicated
that the under 5 year age group was particularly vulnerable
(0.03 cases per 100,000 per year when all deaths are
counted) reflecting the higher incidence of both STEC and
HUS in this age group. The over 50 year age group was
also vulnerable with a higher rate of deaths from HUS
(0.04 cases per 100,000 per year).
From national notifiable data there were 117 notifica-
tions of HUS in the period 2000-2007 and from the
national mortality data 14 deaths where HUS was the
main underlying cause of death, suggesting that 12.0% of
HUS cases died. However, as notification data are not
linked individually to mortality data it is likely that some
deaths from HUS are for cases notified in years outside
the given period if HUS led to chronic problems lasting a
number of years.
Among the 460 STEC cases reported to South Austra-
lia’s notifiable diseases surveillance data in the 13 year
period 1997-2009, there were 14 reported cases of HUS,
giving an estimate of 3% of STEC cases developing
HUS. The annual incidence of HUS associated with
STEC infection in South Australia was 0.1 cases per
100,000 per year. There was no particular serovar
strongly associated with these cases. There were no
deaths from HUS reported in South Australia over this
period [28].
Seasonality of STEC and HUS
The distribution of STEC and HUS cases nationally were
seasonal with a larger proportion of reported cases occur-
ring in the summer months of December to February and
lower numbers in winter (Figure 2).
Burden, incidence and characteristics of STEC outbreaks
Between 2001 and December 2009 there were 11 out-
breaks which were due to STEC, which collectively
affected 117 people (Table 8). Most outbreaks were small,
with a median size of six people affected. There were 29
people (25%) hospitalized and no deaths due to STEC
infections from outbreaks over this period.
Theses outbreaks were reported from South Australia (n
= 5), Queensland (n = 4) and two involved a number of
states; with outbreaks occurring in a variety of settings.
Only two outbreaks were due to foodborne or suspected
foodborne transmission, and for only one of these could a
particular food vehicle be identified (potato salad with
homegrown parsley). Two outbreaks were suspected to be
due to person-to-person transmission, one due to animal-
to-person transmission and one was thought to be due to
waterborne transmission from tank water (as published by
McCall et al. [35]). The mode of transmission in the
remaining five outbreaks remained unknown. One of
these is the outbreak described by Hanna et al. [36] as
being due to possible animal-to-person spread. A number
Table 5 Number of notifications of HUS* by year and
jurisdiction 2000 to 2010
YEAR NSW VIC ACT WA QLD SA TAS NT Total
2000 9 3 0 1 3 1 0 0 17
2001 2 0 0 0 0 1 0 0 3
2002 7 4 0 0 1 0 0 1 13
2003 5 4 0 1 1 3 0 1 15
2004 9 1 0 1 1 3 0 1 16
2005 11 3 0 1 2 1 2 0 20
2006 11 1 0 0 1 1 0 0 14
2007 13 3 1 0 1 1 0 0 19
2008 17 4 0 0 7 2 0 1 31
2009 4 2 0 0 1 4 0 1 12
2010 1 3 0 0 2 0 0 0 8
Total 91 28 1 4 22 17 2 4 169
Yearly Rate/
100,000
0.13 0.05 0.03 0.02 0.05 0.10 0.04 0.05 0.07
*diarrhoea and non diarrhoea associated Source: Data extracted from National
Notifiable Diseases Surveillance System website [26]
Table 6 Notifications of HUS* in Australia 2000 to 2010
by age and sex
Age
Group
Males Females Total Rate notifications per 100,000
per year
< 5 years 33 38 71 0.49
5 - 15
years
16 15 31 0.10
16 - 60
years
15 29 44 0.03
60+ years 9 14 23 0.06
Total 73 96 169 0.07
*diarrhoea and non diarrhoea associated
Table 7 Hospitalisation episodes1 due to HUS* in

















1Principle diagnosis (not including additional diagnoses) *diarrhoea and non
diarrhoea associated HUS included in this table
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of different serotypes were isolated from these outbreaks,
with E.coli O157 thought to have been the infecting sero-
type in four (36.4%) outbreaks. For one outbreak multiple
serotypes were involved.
Discussion
The average annual notified rate of STEC illness over the
past 11 years (2000-2010) in Australia using NNDSS data
was estimated to be 0.4 cases per 100,000 per year, with
an average rate of confirmed O157 STEC illness of 0.12
cases per 100,000 per year. Although it is difficult to see a
clear trend from these national data, rates look to have
increased slightly since 2000. Whilst this may represent a
real increase in the STEC illness rate, there is also evi-
dence that the increase may be linked to an increase in the
number of stool samples tested and changes in laboratory
methods used to detect STEC (unpublished observations).
Variation in rates across states may also be partly
related to variation in testing practices. The number of
stools tested for STEC varies considerably between dif-
ferent states of Australia and this appears to be corre-
lated with STEC notifications rates. The laboratory tests
used to detect STEC also varies between jurisdictions,







Figure 2 Seasonal distribution of STEC and HUS notifications in Australia: percentage of cases by month of onset, 2000-2010.
Table 8 Outbreaks of STEC reported to the OzFoodNet outbreak register 2001-2009, Australia
Year State Transmission mode Number ill Hospitalised Setting Food/water vehicle STEC serotype
2002 SA Animal-to-person 6 0 Petting zoo Not applicable O26:H-
2003 SA Person-to-person 13 2 Aged Care Not applicable O111:H-
2004 QLD Unknown 3 2 Unknown Not applicable O86:H27
2005 SA Unknown 4 3 Community Unknown O111
2007 QLD Unknown 3 1 Unknown Not applicable O55
2007 SA Unknown 12 7 Community Not applicable O157
2008 QLD Waterborne (including recreational water) 2 1 Camp Tank water Multiple serotypes
2009 multi-state Suspected foodborne 14 5 Community Unknown O157:H-
2009 QLD Person-to-person 4 0 Child care Not applicable OR:H7
2009 SA Foodborne 31 5 Camp Potato salad O157
2009 multi-state Unknown 25 3 Community Not applicable O157:H7
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STEC and others incorporating PCR for detection of
stx1 and stx2 genes, which is considered the more sensi-
tive method [37]. The Australian state that tests the
most number of stools is South Australia even though it
does not have a large population compared with many
of the other states of Australia. In this jurisdiction, a
single reference laboratory tests specimens that include
those with evidence of blood in the stool, where there is
a clinical history of blood in the stool, or where the
requesting doctor queries STEC infection or HUS. The
specimens tested are referred from other private and
public health laboratories and so this jurisdiction is con-
sidered to provide Australia with amongst the most
robust estimates internationally for STEC incidence in
bloody diarrhoea [24,28]. However, despite the quality
of the surveillance in this state it is not entirely clear if
STEC rates and epidemiology can be extrapolated from
South Australia to other regions of the country, as
Australia is also a very large country with differing geo-
graphy, climate and demographics.
South Australian surveillance data showed that the 11
year average rate for STEC infections was 2.4 cases per
100,000 per year, which is over 6-fold greater than the
national rate over this period. South Australian STEC inci-
dence rates have remained fairly steady over a consider-
able period, apart from the increase in 2009 due to several
outbreaks in this jurisdiction in that year. As there have
been no major changes in surveillance practices in South
Australia over the last 15 years, this supports the notion
that there has been no real change in the rate of STEC
infections in Australia over this period.
Surveillance practices also vary considerably between
countries and therefore caution is required when com-
paring STEC incidence rates between countries. In parti-
cular, laboratory testing practices vary considerably,
especially the practices for screening stools for blood and
the extent to which genetic testing methods are utilised,
and in addition, the extent to which testing for all sero-
types occurs. In Australia, testing for non O157 serotypes
is an important component of surveillance with most jur-
isdictions conducting STEC testing also using methods
to detect non O157 serotypes [24]. However, testing for
non O157 serotypes does not occur in many countries,
with most focussing mainly on the detection of O157
strains [24,38-41]. In addition, case definitions are not
the same across countries and some reports are for ‘con-
firmed’ cases only, while others include ‘probable’ cases.
Some countries have passive or voluntary reporting,
while others are mandated by law or actively pursued.
Furthermore, multiple STEC infections in one person
may be reported as separate infections or as one case.
Even within countries there is variation in testing and
reporting. For example, in the Netherlands only some
parts of the country test for non-O157 [38]. Also, in the
United States, only 7% of 428 clinical laboratories sur-
veyed used enzyme immunoassay, a non-culture method
for the detection of non O157 cases [40].
Bearing in mind the need for caution regarding inter-
pretation, Australian rates appear to be lower than coun-
tries in Europe that have similar surveillance practices
and report confirmed cases of both O157 and non O157
STEC. Even the higher rates obtained from the South
Australian surveillance system are comparable to rates
reported in these countries. The Community Summary
Report on the European Union in 2008 [38] gives the
incidence of all STEC infections in 2008 in Austria, Bel-
gium and Norway as 1 case per 100,000 or less; and Den-
mark, Sweden and Ireland as 2.9, 3.3 and 4.8 cases per
100,000, respectively. New Zealand, Australia’s nearest
neighbour, reported STEC in 2009 at a rate of 3.3 cases
per 100,000 per year [42]. In many countries the vast
majority of reported STEC cases were serotype O157,
including Scotland, Ireland, the United Kingdom as a
whole, the United States and Canada. In Scotland in the
period 1998-2007, the annual average incidence of O157
infections was 4.3 cases per 100,000 per year [39]. In Ire-
land in 2009, O157 incidence was 3.9 cases per 100,000
per year [43] whilst in the whole of the United Kingdom
in 2008 it was reported to be 1.9 cases per 100,000 per
year [38]. In the United States, between 2000- 2006, data
gathered from eight FoodNet surveillance sites gave an
incidence of O157 of 1.5 cases per 100,000 per year [44].
In Canada in 2007 the incidence of O157 was 2.9 cases
per 100,000 per year [41]. It should be noted that all of
these rates are higher than the incidence rate for con-
firmed O157 for South Australian of 0.7 cases per
100,000 per year in the period 1997-2009.
The overall incidence of HUS in Australia in the 11 year
period 2000-2010 was 0.07 per 100,000 per year with chil-
dren under 5 years having the highest rate of 0.49 cases
per 100,000 per year. It is important to recognise that
HUS can be due to various causes and not all cases are
secondary to STEC infection. An estimate by a group of
Australian foodborne disease experts in 2005 suggested
that about 50% of cases were secondary to STEC infection
[45]. Other evidence suggests the proportion could be as
high as 88%, with 139 out of 160 HUS cases reported to
the Australian Paediatric Surveillance Unit between 1994
and 2001 being diarrhoea associated [46].
National hospital separation data showed more episodes
of hospitalisation for HUS than the number of cases noti-
fied to national surveillance. Firstly, it is likely that patients
with HUS may have multiple hospital admissions, espe-
cially as they may be transferred to specialist units and so
are recorded as more than one hospital admission episode.
Furthermore, any cases proceeding to dialysis may require
many admissions. Cases from earlier years that developed
chronic renal failure due to HUS may still appear in this
Vally et al. BMC Public Health 2012, 12:63
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hospitalisation data in this time period for treatment. It is
also possible that some hospitalised cases are not reported
to the national surveillance system. There may be some
cases that were not STEC but other types of E.coli infec-
tion included in the codes used to identify episodes of hos-
pitalisations attributed to STEC. On the other hand, there
are also likely to be other STEC infections coded to diar-
rhoea of presumed infectious origin. A validation study
linking notifications, hospitalisations and deaths would be
valuable to clarify this issue.
Worldwide, case control studies of varying sizes and
rigour have been conducted aiming to examine risk fac-
tors for sporadic O157 STEC infection. In many of the
larger well conducted North American studies a signifi-
cant association between illness and the consumption of
hamburgers, pink or undercooked hamburgers, pinkish
ground beef, undercooked meat, or barbequed food, has
been demonstrated [47-51]. In addition to this, eating in
restaurants or fast food restaurants were also identified
as risk factors [48,49]. Living or working or visiting a cat-
tle farm [47] and visiting a farm with cows [48] were also
both found to be strongly associated with O157 STEC
infection in two of the larger United States studies com-
pleted. Drinking untreated surface water, drinking well
water, or swimming in a pond were other environmental
exposures associated with infection in these North Amer-
ican studies. Other case control studies have indicated
the association between illness and contact with animal
faeces [52], consumption of raw milk [53] and consump-
tion of cold cooked sliced meats [54]. Evidence of house-
hold transmission has also been obtained, with an
association between STEC infection and the presence in
the household of a child under the age of 2 years [48], a
child with diarrhoea [55], or anyone with diarrhoea [49].
In Australia, two case control studies have examined risk
factors for sporadic STEC infection. In South Australia in
2002 cases were more likely than controls to have eaten
berries, including strawberries, blueberries and blackber-
ries, in the 10 days preceding illness [56]. This finding is
interesting, although the study was small and this finding
needs to be interpreted with caution. Another Australian
study [57] recruited 114 cases and risk factors for infection
were analysed for those infected with O157 serotypes and
non-O157 serotypes of STEC. Risk factors for O157 infec-
tion in this study included eating hamburgers, visiting res-
taurants, having previously used antibiotics, having direct
contact with red meat through occupational exposures or
having another member of the household having occupa-
tional exposure to red meat. The risk factors for O157
infection in this Australian study were largely similar to
those reported in international studies; however, con-
sumption of hamburgers and ground beef has not been
previously thought to be an important cause of STEC
infections in Australia so this finding is of considerable
interest. Risk factors for non O157 infection included hav-
ing eaten sliced chicken meat or corned beef from a deli-
catessen, having camped in the bush, having eaten catered
meals, or having had family occupational exposure to ani-
mals. The grouping of all non O157 serotypes in this
study into one group assumes that different serovars have
similar characteristics and risk factors which is a limita-
tion; however, the identification of different risk factors for
O157 and non O157 STEC almost certainly reflects differ-
ing reservoirs for these serogroups in Australia.
STEC outbreaks appear to affect less people in Australia
compared to many countries. A total of 117 cases were
reported as part of 11 outbreaks in Australia as a whole in
the nine year period between 2001-2009, a crude rate of
0.5 outbreaks per million population per year and repre-
senting approximately 15% of all STEC cases reported.
This is much lower than the proportion of outbreak cases
in some other comparable countries. For example, in Ire-
land, 50% of cases in 2009 were related to 42 outbreaks in
that year [43]. In New Zealand between 2006 and 2009
there were 19 outbreaks of STEC, three of them foodborne
[42,58]. In 2008 in the European Union, there were 75
foodborne outbreaks of STEC and other pathogenic E.coli,
up from 65 outbreaks in 2007 [59]. The largest numbers
of outbreaks reported from a single country were in
Germany (28 outbreaks) and Austria (11 outbreaks) with
only four reported from the United Kingdom. In the Uni-
ted States in 2007 there were 40 outbreaks of STEC [60].
In the United States, ground beef appears has posed the
most significant public health risk and has been the food
most commonly implicated in reported STEC outbreaks,
although over time there have been major outbreaks
attributed to other sources, such raw milk products, fresh
produce, juice, sprouted seeds and spinach [12-19,61]. In
2007, five out of six multi-state outbreaks of E.coli O157:
H7 were due to ground beef [60]. Many of the outbreaks
found to be due to ground beef over the years have been
extremely large in size and have affected up to many hun-
dreds of individuals [9,62]. The majority of these outbreaks
were most likely to have been due to beef where contami-
nation was disseminated in product during the grinding
process and then undercooked during preparation [3]. It is
important to mention that in addition to the 11 outbreaks
in Australia reported between 2001 and 2009, there was
also a significant STEC outbreak in South Australia in
1995, with 23 HUS cases in children and one death asso-
ciated with the consumption of mettwurst, a fermented
but uncooked meat product [27].
The epidemiology of STEC serotypes suggests O157
strains have been less dominant in Australia than the
United States, England, Wales, Scotland and Japan, both
in terms of sporadic cases, and particularly as a cause of
outbreaks. As mentioned earlier, in many countries,
including the United States [40], O157 has been the
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focus of testing regimes, and this goes some way towards
explaining the predominance of this strain in surveillance
data from these countries. In Australia, testing for non
O157 serotypes does occur routinely and has shown that
O111, O26, O113, O55 and O86 strains are also com-
monly associated with STEC illnesses.
The burden of illness associated with STEC and HUS is
considerable. A study exploring the economic costs of
STEC infection in South Australia between 2003 and 2006
found that of the 3-7% of sporadic STEC patients who
developed HUS, 40% had ongoing medical issues [63]. In
this study, 19 out of 43 STEC cases were admitted to hos-
pital (44%). The estimated average cost of STEC infection
was AUD 3,132 per case. It is also likely that in every
country, the reported burden is an underestimate and that
there are cases in the community that are not tested and
reported [64]. In South Australia, it has been estimated
that there are around eight (95% credible interval 3-75)
cases in the community for every case detected by surveil-
lance [65]. After accounting for under reporting of STEC
to surveillance, this equated to a cost of AUD 2,633,181
for Australia each year.
Conclusions
In Australia STEC is a public health problem that needs to
be addressed, as it does throughout the developed world.
Whilst international comparisons of STEC infection rates
are extremely difficult due to differing surveillance prac-
tices, and there is a need for caution in the interpretation
of this data, the estimated incidence rates for STEC in
Australia appear to be comparable or lower than the levels
in similar countries. This is generally maintained even
when using South Australian STEC surveillance data as a
proxy for Australian STEC infection rates, with this juris-
diction having the most comprehensive surveillance in the
country that is likely to be providing estimates closer to
the true rate of infection for this pathogen than estimates
from many other countries. In contrast to the United
States and many other countries in which STEC outbreaks
are a considerable problem and are primarily due to the
foodborne transmission route, STEC outbreaks in Austra-
lia are less common and have been found to be less often
associated with foodborne transmission. In conclusion, as
surveillance and laboratory testing practices continually
improve across Australia in the next few years, so will our
understanding of the epidemiology of this pathogen in this
country and our ability to target interventions.
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